In contrast, the cases involving anti-Ma2 antibodies have all occurred in patients with tumors not normally associated with anti-Ma2 antibody response, including renal cell carcinoma (119, 121, 128). This evidence concerns the gene PNMA2 and renal cell carcinoma.